The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.
Saved in:
| Title: | The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study. |
|---|---|
| Authors: | Fader AN; Johns Hopkins Medical Institutions, Baltimore, MD, USA. Electronic address: afader1@jhmi.edu., Java J; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY, USA., Krivak TC; Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Bristow RE; University of California Irvine, Orange, CA, USA., Tergas AI; Johns Hopkins Medical Institutions, Baltimore, MD, USA., Bookman MA; Arizona Cancer Center, Tucson, AZ, USA., Armstrong DK; Johns Hopkins Medical Institutions, Baltimore, MD, USA., Tanner EJ; Johns Hopkins Medical Institutions, Baltimore, MD, USA., Gershenson DM; University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA. |
| Source: | Gynecologic oncology [Gynecol Oncol] 2014 Mar; Vol. 132 (3), pp. 560-5. Date of Electronic Publication: 2013 Dec 13. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1095-6859 |
|---|---|
| DOI: | 10.1016/j.ygyno.2013.11.016 |
